Logo image of PRTO

Proteon Therapeutics Inc. (PRTO) Stock Price, Quote, News and Overview

NASDAQ:PRTO - Nasdaq -

0.8352  +0.19 (+28.45%)

After market: 0.712 -0.12 (-14.75%)

PRTO Quote, Performance and Key Statistics

Proteon Therapeutics Inc.

NASDAQ:PRTO (1/9/2020, 8:26:19 PM)

After market: 0.712 -0.12 (-14.75%)

0.8352

+0.19 (+28.45%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High3.94
52 Week Low0.22
Market Cap18.52M
Shares22.18M
Float7.31M
Yearly Dividend0
Dividend Yield0%
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


PRTO short term performance overview.The bars show the price performance of PRTO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150 200

PRTO long term performance overview.The bars show the price performance of PRTO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of PRTO is 0.8352 null. In the past month the price increased by 161%. In the past year, price decreased by -66.46%.

Proteon Therapeutics Inc. / PRTO Daily stock chart

About PRTO

Company Profile

Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201, a recombinant human elastase, applied in a single treatment to the external surface of arteries and veins during an open surgical procedure or an endovascular intervention. Proteon Therapeutics Inc. is headquartered in Waltham, Mass.

Company Info

Proteon Therapeutics Inc.

200 WEST STREET

WALTHAM MA 02451

CEO: Timothy P. Noyes

Phone: 781-890-0102

Proteon Therapeutics Inc. / PRTO FAQ

What is the stock price of Proteon Therapeutics Inc. today?

The current stock price of PRTO is 0.8352 null. The price increased by 28.45% in the last trading session.


What is the ticker symbol for Proteon Therapeutics Inc. stock?

The exchange symbol of Proteon Therapeutics Inc. is PRTO and it is listed on the Nasdaq exchange.


On which exchange is PRTO stock listed?

PRTO stock is listed on the Nasdaq exchange.


What is Proteon Therapeutics Inc. worth?

Proteon Therapeutics Inc. (PRTO) has a market capitalization of 18.52M null. This makes PRTO a Nano Cap stock.


What are the support and resistance levels for Proteon Therapeutics Inc. (PRTO) stock?

Proteon Therapeutics Inc. (PRTO) has a support level at 0.28. Check the full technical report for a detailed analysis of PRTO support and resistance levels.


Should I buy Proteon Therapeutics Inc. (PRTO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Proteon Therapeutics Inc. (PRTO) stock pay dividends?

PRTO does not pay a dividend.


What is the Price/Earnings (PE) ratio of Proteon Therapeutics Inc. (PRTO)?

Proteon Therapeutics Inc. (PRTO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.96).


PRTO Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to PRTO. When comparing the yearly performance of all stocks, PRTO is one of the better performing stocks in the market, outperforming 97.6% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PRTO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PRTO. While PRTO seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRTO Financial Highlights

Over the last trailing twelve months PRTO reported a non-GAAP Earnings per Share(EPS) of -0.9600000000000001. The EPS increased by 18.64% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -193.21%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%68%
Sales Q2Q%N/A
EPS 1Y (TTM)18.64%
Revenue 1Y (TTM)N/A

PRTO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 73% to PRTO. The Buy consensus is the average rating of analysts ratings from 3 analysts.


Ownership
Inst Owners23.03%
Ins Owners31.18%
Short Float %N/A
Short RatioN/A
Analysts
Analysts73.4
Price TargetN/A
EPS Next Y32.17%
Revenue Next YearN/A